| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |